Disclaimer: This website has been created by an unlicensed individual shareholder of BrainChip, Inc. Brainchip does not endorse or take responsibility for any of the content or opinions on this website. No advice given, opinions only. Please do your own research.

Timeline Story Upcoming events Links

The Brainchip Story - 2016 to December 2020

Authored by @Fact Finder - December 2020 - (Original post)

Chapter One

The Brainchip story is not one which is well known by the general public for a number of reasons not the least of which is the fact that Brainchip for obvious commercial reasons has been operating as much as possible under the radar to protect its commercial and intellectual advantage in the field of Spiking Neural Network technology.

Recently however with the signing of its first commercial Intellectual Property Licence agreement it has moved out of the shadows of being a start up in self-imposed stealth mode to becoming a major international semiconductor provider heralding a new era of artificial intelligence at the edge and far edge both here on Earth and in Space.

The journey to this point commenced over twenty years ago when Peter van der Made commenced to formalise his ideas for how to conceive artificial general intelligence. These ideas were developed by him until in 2008, when he filed the foundational Patent number 8250011 for what was to become Brainchip's spiking neural network technology known as AKIDA.

Along this journey other visionaries joined him and in 2015 as a result of Peter van der Made's previous experiences with the venture capital model Brainchip Technologies Ltd was born out of a reverse takeover of the dormant minerals explorer Aziana on the Australian Stock Exchange. Supported by Mick Bolto Chairman, Adam Osserian Non Executive Director, Anil Mankar Chief Operating Officer and Senior Engineer and Neil Rinaldi Non Executive Director, Peter van der Made commenced the journey towards the commercialisation of his original idea for artificial general intelligence. This caused much excitement among investors on the ASX and many captivated by the idea of artificial general intelligence bought shares priced purely on a collective vision of what the future could hold for Brainchip's technology.

In October, 2015 an investor presentation by the company announced the introduction of SNAP. SNAP was the first iteration of SNN technology and stood for Spiking Neuron Adaptive Processor. The business model involved initially the sale of the intellectual property however the early high expectations were not to be delivered. There are lots of reasons but suffice to say having the most advanced revolutionary technology in the world can be a hard sell to a world which is happy with the status quo and who have no idea what you are talking about and no interest in learning. In short SNAP in all its variants was ahead of its time and not market ready and Moore's Law had yet to reach breaking point.

On 1 September, 2016 the company completed the acquisition of a French based company Spikenet Technology which specialised in Ai computer vision technology with a view to accelerating up take of SNAP technology as a video processing solution. Spikenet had a relationship with Cerco Research Centre where Dr Simon Thorpe (now a member of the Brainchip Scientific Advisory Board) undertook research with others and in that position had developed the JAST learning rules.

The term JAST was made up from the first initials of the four inventors and Brainchip saw the benefit these rules would bring to the development of its technologies and on 20 March, 2017 entered an agreement which gave them exclusive rights to the JAST learning rules.

Bringing together the expertise of Spikenet, Brainchip and the JAST learning rules on 12 September, the company produced a new video processing product which it named Brainchip Studio. It was a very impressive product and was unlike anything else available on the market and on 21 August 2017 Brainchip announced that it had been awarded New Product of the Year for 2017 for Video Analytics by Security Today's panel of independent experts. Shortly after this on 12 September, 2017 the company announced an upgrade to Brainchip Studio called Brainchip Accelerator which was capable of 16 channel simultaneous video processing, with ultra low power and 6x speed boost to Brainchip Studios CPU-based Artificial Intelligence Software for Object Recognition and performance levels 7 times more efficient than existing GPU accelerated deep learning systems.

Brainchip Accelerator went on to also win an industry award however the market place in which it was released was already dominated by well known global brands and proved to be impenetrable until the then new CEO Lou Dinardo announced the signing of what was in effect a Heads of Agreement with Gaming Partners International to develop a system built on Studio technology for game table security in the Casino industry. The agreement involved the upfront payment by Gaming Partners International of $500,000 as well as an additional payment of $100,000 to cover engineering works. These payments were made and it was full steam ahead and the project was reportedly on track and successful demonstrations of the prototype had gone down well at a Gaming Industry conference in the USA.

The saying 'never seems to be able to catch a break' comes to mind as not long into the process of designing and building this table gaming solution Gaming Partners International became the subject of a successful takeover bid by a Japanese gaming company and in the wash up of that takeover the Japanese owners were not interested in pursuing this direction as their principle reason for acquiring GPI was to add GPI's chip technology to their playing card business. After much negotiation it became obvious to Brainchip that it was a zero sum game trying to revive the project although both parties have agreed to revisit it in the future.

Chapter Two

The decision was made by Brainchip to go for the end goal in a make or break effort to achieve the companies 'holy grail' and Peter van der Made stepped aside from his position on the Board of Directors to work exclusively on the final stage of the development of the AKIDA technology. The company engaged in brutal cost savings and shedding of all staff not engaged in the technology engineering side of the company.

All of the knowledge and research that had gone into the various attempts at commercialisation had also driven the advance of the AKIDA technology platform so Peter van der Made and Anil Mankar had the plan already laid out as to what was required, but now it became a race not just to be the first to market that would be a given but a race to finalise the research and engineering in record time before the company was no longer financially viable.

The various decisions as to how to make the final push to market of this revolutionary product were brilliant. They knew that this would be make or break. They knew they had the technology but they knew from the past failures that they had to pick an area or segment of the market where they would not have any true competition. They also knew that even then they needed to have found out before they built the product what clients thought of it and what they liked and did not like about it all on a shoestring budget.

The idea of the Akida Development Environment (ADE) was conceived and it was released to early access customers. Studio had been released to customers after being produced and as a result feedback from customers came too late in the cycle but nonetheless this feedback was available to inform Brainchip as to what the ADE should look like. However by releasing the ADE in advance it was intended that any further feedback would be taken on board and designed in which in fact occurred however to accommodate these customer requests the release date of the IP and the production of AKIDA1000 was delayed by twelve months as Peter van der Made and Anil Mankar went back to the drawing board.

The state of the Brainchip balance sheet and the delay that this redesign caused did not go down well with many shareholders and a great deal of angst and anger were directed at the company in particular the CEO which suffice to say he fielded with a dignified air but which to those who had been involved watching the company since he took up his role clearly weighed heavily on his shoulders. In an extremely positive sign on 14 December, 2019 a joint presentation of the ADE performing hand gesture identification took place at a trade show in combination with Tata Consulting Service engineers and to the delight of many shareholders one of the presentation slides stated that the Tata engineers were looking forward to building a robot based upon an AKIDA platform.

Anil Mankar has a strong background in bringing IP to successful implementation on chip and it is reported that he has over 100 successful chip designs to his credit. As a result despite the speed which was required he ensured that the company took the time to implement the AKD1000 design in FPGA before taking it to Socionext for final engineering and design prior to sending it to TSMC for production of the wafer. In an effort to contain the costs of producing the AKD1000 chip the company decided that it would share a wafer and on 8 April, 2020 TSMC commenced production.

These actions of going back to the drawing board following feedback from early access customers and implementing the design on FPGA produced delays which clearly did not impress the market and it was reflected in an ever falling share price but the company stuck with what had to be done to achieve the end result.

Chapter Three

While the engineering and tech people were burning the midnight oil the task of marketing the ADE the IP and the eventual AKD1000 boards and raising capital fell to the CEO and Mr Roger Levinson. Despite Covid-19 these two individuals managed to leverage their contacts around the globe to the extent that despite significant shareholder criticism at the time the company announced a 29 million dollar funding arrangement with LDA Capital ensuring the companies financial viability. Shareholders waited to find out if the AKD1000 which had been through testing and packaging by Socionext would also pass validation tests conducted by the company before installing them on Boards and shipping them to customers. Everything seemed to be falling into place.

In a tribute to the chip design work of Anil Mankar the CEO announced that final validation and testing proved the AKD1000 worked perfectly matching and exceeding all predicted benchmarks something which he had not witnessed in all his years in the semiconductor industry.

While all these milestones were being achieved the CEO was keeping shareholders up to date with progress on the marketing and engagement side of the company and over time announced that Brainchip had well north of 100 Non Disclosure Agreements in place with various interested companies and that they had selected from the interested companies about two dozen which stood out as household names, Fortune 500 companies and most likely to bring commercial benefit. It is indeed difficult to know when the CEO found the time, given that after Peter van der Made stepped down from the Board to concentrate all his efforts on finalising the design of AKD1000 all administrative and sales staff were let go, yet he was able to finalise and announce early access and development agreements with Ford and Valeo both well known Tier 1 companies in the automotive industry where such agreements involved these companies paying Brainchip for the privilege of receiving early access to the AKD1000 test boards.

In a further coup the CEO announced the appointment of Mr Rob Telson as Vice President of World Wide Sales. Rob Telson had been at ARM and had filled the roles of Vice President of Foundry Sales World wide and also Vice President of Sales for the Americas. It is interesting to note that with this appointment Brainchip seemed to be confirming that its stated intention in 2015 to use ARM as its model for building its global footprint still was in play.

The CEO not one to let grass grow also jointly announced with Socionext an agreement to include the AKD1000 chip as part of the Socionext SynQuacer product offering and also a joint development agreement with Magik-Eye the inventor of a revolutionary 3D point sensor capable of depth perception. Then out of left field the CEO announced an Early Access Customer engagement with Vorago for the purpose of Vorago hardening the AKD1000 chip for space deployments in a fully funded Phase 1 program with NASA. Not long after this announcement the CEO announced that NASA had directly been admitted to the Early Access Program.

Chapter Four

While all this has been taking place Peter van der Made having completed the AKD1000 design has with Anil Mankar moved on to the designs for AKD2000 and AKD3000 while at the same time working with Adam Osseiran and others on the AERO project. The AERO project started life as a way to leverage the ADE to identify gases and in the process created a design for a scientific instrument powered by the ADE using only 200 AKIDA neurons which was capable of state of the art identification of the 20 gas data set (of ten gases) with latency of only 3 seconds. This breakthrough research has led to trialling the ADE as the (processor) for identifying Volatile Organic Compounds of various diseases from samples of exhaled human breath.

As luck would have it Adam Osseiran's work with Noble Laureate Professor Barry Marshall on the invention of the Noisy Gut Belt has led to Professor Marshall becoming aware of the AKIDA technology and accepting an invitation to join the BrainChip Scientific Advisory Board for the purpose of developing medical diagnostic applications relating to AERO and its proven capacity to identify gases for the purpose of identify various medical conditions in real time from sampling exhaled human breath.

The Brainchip Scientific Advisory Board is presently chaired by Adam Osseiran with Professor Barry Marshall and Dr Simon Thorpe. In a presentation by Peter van der Made to the Brain Inspired Computing Congress in November, 2020 he confirmed that AKIDA had been successfully implemented as the processor for the purpose of identifying Covid-19 with a success rate of 94%. It is well recognised that various diseases including some cancers, diabetes and Covid-19 express themselves in identifiable patterns when exhaled on an infected person's breath.

The potential low cost, unconnected, portable nature of an AKIDA medical scientific instrument for this purpose could be life changing for remote populations and people of developing countries. The ability to incorporate this technology into telehealth applications which have grown exponentially in developed countries as a result of Covid-19 infection promises huge commercial opportunities and together these factors could provide greater equality of access to modern medical services than at any time in history of the world. In fact researchers at Australia's own Flinders' University have in recent months announced that they have identified VOC markers in exhaled human breath for head and neck cancer.

Chapter Five

On more than one occasion the CEO of Brainchip has stated to shareholders in presentations during the second half of 2020 that the company was very close to announcing its first commercial engagement and that this announcement may come late 2020 but certainly early 2021. Well to the amazement of shareholders as Christmas descended and the markets started to wind down the CEO was true to his word as a trading halt was called on the 22 December, 2020 and after the close of trade on 23 December, 2020 the CEO and the Board of Brainchip released two announcements.

The first was confirmation that Brainchip had been awarded a sole source contract with NASA for the AKIDA early access development kit. The second and pivotal announcement was that the first Intellectual Property licence had been entered with Renesas with the CEO commenting: "This is an exciting and significant milestone in obtaining the Company's first IP licensing agreement. Furthermore, this is a market validation of our technology."

The salient terms of this agreement as announced are: Aliso Viejo, Calif. - 23 December 2020 - BrainChip Holdings Ltd (ASX: BRN), a leading provider of ultra-low power, high- performance AI technology, today announced the signing of an intellectual property license agreement with Renesas Electronics America Inc., a subsidiary of Japan-based Renesas Electronics Corp., a tier-one semiconductor manufacturer that specializes in microcontroller and automotive SoC products.

The unconditional agreement provides for:

So after this announcement the next trading day being 24 December, 2020 trading resumed and the market closed early because it was Christmas Eve. The next chapter in the Brainchip story will now unfold with expectations of further IP agreements, mass production of the AKD1000 and many exciting new ventures being anticipated. The rest of the Brainchip story is likely to be written in front of an increasingly attentive market both here in Australia and around the world and is likely not to require someone to put it in writing as AKIDA technology becomes ubiquitous both on Earth and in Space.

Chapter Six

In finalising this first book of Brainchip I have included below some of the patents and published research to complete the historical picture noting that there are still a number of patents in progress:

Patents:

Published Research:

The End.